I
ROIV icon

InceptionR’s Roivant Sciences ROIV Stock Holding History

InceptionR’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Sell
11,168
-9,674
-46% -$286K 0.1% 387
2026
Q1 		$577K Sell
20,842
-19,568
-48% -$503K 0.14% 269
2025
Q4 		$877K Sell
40,410
-25,649
-39% -$506K 0.24% 142
2025
Q3 		$999K Buy
66,059
+32,703
+98% +$405K 0.24% 128
2025
Q2 		$376K Buy
+33,356
New +$362K 0.09% 383

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

InceptionR's ROIV Position: Q2 2026 in Review

InceptionR reduced its Roivant Sciences (ROIV) stake by 46% in Q2 2026, selling an estimated $286K and leaving 11,168 shares worth $395K. The position accounts for 0.1% of the portfolio, ranked #387.

InceptionR first reported a position in ROIV in Q2 2025 and has held it in 5 quarters since. The position peaked at $999K in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • InceptionR held 11,168 shares of Roivant Sciences worth $395K as of Q2 2026.
  • InceptionR sold 9,674 Roivant Sciences shares in Q2 2026, an estimated $286K.
  • Roivant Sciences made up 0.1% of InceptionR's portfolio in Q2 2026, its #387 holding.
  • InceptionR first reported a position in Roivant Sciences in Q2 2025 and has held it in 5 quarters since.
  • InceptionR's Roivant Sciences position peaked at $999K in Q3 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.